ENVB
Price
$1.21
Change
-$0.03 (-2.42%)
Updated
Jun 13 closing price
Capitalization
2.99M
PULM
Price
$7.81
Change
-$0.17 (-2.13%)
Updated
Jun 13 closing price
Capitalization
28.52M
52 days until earnings call
Interact to see
Advertisement

ENVB vs PULM

Header iconENVB vs PULM Comparison
Open Charts ENVB vs PULMBanner chart's image
Enveric Biosciences
Price$1.21
Change-$0.03 (-2.42%)
Volume$100.8K
Capitalization2.99M
Pulmatrix
Price$7.81
Change-$0.17 (-2.13%)
Volume$16.49K
Capitalization28.52M
ENVB vs PULM Comparison Chart
Loading...
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENVB vs. PULM commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a Hold and PULM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (ENVB: $1.21 vs. PULM: $7.81)
Brand notoriety: ENVB and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 41% vs. PULM: 95%
Market capitalization -- ENVB: $2.99M vs. PULM: $28.52M
ENVB [@Biotechnology] is valued at $2.99M. PULM’s [@Biotechnology] market capitalization is $28.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whilePULM’s FA Score has 0 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, PULM is a better buy in the long-term than ENVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 4 TA indicator(s) are bullish while PULM’s TA Score has 5 bullish TA indicator(s).

  • ENVB’s TA Score: 4 bullish, 3 bearish.
  • PULM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ENVB is a better buy in the short-term than PULM.

Price Growth

ENVB (@Biotechnology) experienced а -6.92% price change this week, while PULM (@Biotechnology) price change was -12.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

PULM is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PULM($28.5M) has a higher market cap than ENVB($2.99M). PULM YTD gains are higher at: 11.891 vs. ENVB (-77.493). ENVB has higher annual earnings (EBITDA): -9.01M vs. PULM (-9.58M). PULM has more cash in the bank: 7.71M vs. ENVB (4.29M). ENVB (0) and PULM (0) have identical debt. PULM has higher revenues than ENVB: PULM (1.92M) vs ENVB (0).
ENVBPULMENVB / PULM
Capitalization2.99M28.5M10%
EBITDA-9.01M-9.58M94%
Gain YTD-77.49311.891-652%
P/E RatioN/AN/A-
Revenue01.92M-
Total Cash4.29M7.71M56%
Total Debt00-
FUNDAMENTALS RATINGS
ENVB vs PULM: Fundamental Ratings
ENVB
PULM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9436
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (15) in the Electronics Or Appliances industry is in the same range as PULM (47) in the Biotechnology industry. This means that ENVB’s stock grew similarly to PULM’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as PULM (100) in the Biotechnology industry. This means that ENVB’s stock grew similarly to PULM’s over the last 12 months.

PULM's SMR Rating (98) in the Biotechnology industry is in the same range as ENVB (99) in the Electronics Or Appliances industry. This means that PULM’s stock grew similarly to ENVB’s over the last 12 months.

PULM's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for ENVB (94) in the Electronics Or Appliances industry. This means that PULM’s stock grew somewhat faster than ENVB’s over the last 12 months.

PULM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that PULM’s stock grew similarly to ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBPULM
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 28 days ago
78%
Bullish Trend 19 days ago
70%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SXI152.71-3.11
-2.00%
Standex International Corp
IH2.34-0.06
-2.50%
iHuman
RGEN127.52-3.78
-2.88%
Repligen Corp
TANH1.99-0.12
-5.69%
Tantech Holdings Ltd.
TNGX4.69-0.36
-7.13%
Tango Therapeutics

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with VANI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
-2.42%
VANI - ENVB
42%
Loosely correlated
-3.36%
CDXS - ENVB
27%
Poorly correlated
-0.89%
VTVT - ENVB
26%
Poorly correlated
-4.06%
ENTX - ENVB
25%
Poorly correlated
-11.00%
KPTI - ENVB
24%
Poorly correlated
+0.69%
More

PULM and

Correlation & Price change

A.I.dvisor tells us that PULM and INM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PULM and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
-2.13%
INM - PULM
29%
Poorly correlated
-5.95%
CRIS - PULM
24%
Poorly correlated
-11.55%
CERO - PULM
23%
Poorly correlated
-7.12%
MOLN - PULM
23%
Poorly correlated
-1.54%
ENVB - PULM
22%
Poorly correlated
-2.42%
More